02.02.2013 Views

Health Inequities in Manitoba: Is the Socioeconomic Gap

Health Inequities in Manitoba: Is the Socioeconomic Gap

Health Inequities in Manitoba: Is the Socioeconomic Gap

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Health</strong> <strong>Inequities</strong> <strong>in</strong> <strong>Manitoba</strong>: <strong>Is</strong> <strong>the</strong> <strong>Socioeconomic</strong> <strong>Gap</strong> <strong>in</strong> <strong>Health</strong> Widen<strong>in</strong>g or Narrow<strong>in</strong>g Over Time?<br />

Multiple Sclerosis (MS)<br />

Def<strong>in</strong>ition<br />

Multiple sclerosis is a degenerative disease of <strong>the</strong> central nervous system (bra<strong>in</strong> and sp<strong>in</strong>al cord).<br />

Its effects are diverse, and may <strong>in</strong>clude problems <strong>in</strong> balance, vision, communication, memory, and<br />

movement, as well as more general symptoms such as pa<strong>in</strong> and fatigue. The course of disease varies<br />

between people. Some may have long periods of remission between active episodes, while o<strong>the</strong>rs<br />

may have progression of symptoms from <strong>the</strong> time of onset, and still o<strong>the</strong>rs may have an <strong>in</strong>itial period<br />

of relapses and remissions followed by a progressive course. MS is treatable through a variety of<br />

modalities, which have a variable impact on <strong>the</strong> progress of <strong>the</strong> disease; however, a cure for MS is not<br />

yet available.<br />

MS six–year period prevalence has been calculated as <strong>the</strong> age– and sex–adjusted number of cases of<br />

MS per 100,000 population aged 16 or older <strong>in</strong> a six–year period. In this report, we identified cases of<br />

MS meet<strong>in</strong>g <strong>the</strong> follow<strong>in</strong>g criteria: at least three hospital visits, three physician visits, or a comb<strong>in</strong>ation<br />

of <strong>the</strong>se where each visit <strong>in</strong>cluded a diagnosis code for MS with<strong>in</strong> a period of six years. ICD codes for MS<br />

are <strong>in</strong>cluded <strong>in</strong> <strong>the</strong> Glossary.<br />

Time Period Six–year period prevalence per 100,000<br />

T1: 1984/85–1989/90 245.58<br />

T2: 1990/91–1995/96 252.06<br />

T3: 1996/97–2001/02 278.21<br />

T4: 2002/03–2007/08 275.65<br />

Key F<strong>in</strong>d<strong>in</strong>gs: Multiple Sclerosis (MS)<br />

<strong>Manitoba</strong> overall rates:<br />

• From <strong>the</strong> first time period T1 (1984/85–1989/90) to <strong>the</strong> last time period T4 (2002/03–2007/08), <strong>the</strong><br />

prevalence of diagnosed MS <strong>in</strong> <strong>Manitoba</strong> <strong>in</strong>creased gradually overall, from 246 to 276 per 100,000<br />

aged 16 and older.<br />

Rates by neighbourhood <strong>in</strong>come qu<strong>in</strong>tile over time:<br />

Rural:<br />

• Compar<strong>in</strong>g T1 to T4, <strong>the</strong> prevalence of diagnosed MS among rural residents <strong>in</strong>creased <strong>in</strong> all<br />

neighbourhood <strong>in</strong>come qu<strong>in</strong>tiles. The greatest <strong>in</strong>crease <strong>in</strong> prevalence was <strong>in</strong> <strong>the</strong> R5 qu<strong>in</strong>tile, followed<br />

by R2 and R3.<br />

• R1 (lowest neighbourhood <strong>in</strong>come qu<strong>in</strong>tile) had <strong>the</strong> lowest prevalence across all time periods.<br />

<strong>Manitoba</strong> Centre for <strong>Health</strong> Policy 105

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!